SER
$1.34
Post-MarketAs of Mar 17, 8:00 PM UTC
Serina Therapeutics, Inc., a biotechnology company, develops drugs to treat neurological diseases and pain.
Recent News
Fed Politics Weigh on Investor Sentiment, Driving Muted Premarket Action for US Equity Futures
US equity futures were flat ahead of Tuesday's opening bell after President Donald Trump said he was
Exchange-Traded Funds, Equity Futures Lower Pre-Bell Tuesday as Investors Await Economic Data, Trump Orders to Remove Lisa Cook
The broad market exchange-traded fund SPDR S&P 500 ETF Trust (SPY) was down 0.1% and the actively tr